Susceptibility of Neisseria gonorrhoeae to pefloxacin. 1987

K P Chan, and E H Sng, and S T Koh
Department of Pathology, Singapore.

144 strains each of penicillinase producing (PPNG) and non-penicillinase producing (NPPNG) Neisseria gonorrhoeae were tested for susceptibility to pefloxacin. All isolates but one (99.65%) were susceptible to 0.06 mg/l. No significant difference was detected between the minimum inhibitory concentrations (MICs) of PPNG and NPPNG strains. The MIC50 and MIC90 of both types of strains were 0.015 mg/l and 0.06 mg/l respectively. Since pefloxacin was more effective than norfloxacin and rosoxacin against PPNG as well as NPPNG, it should prove useful in the therapy of gonorrhoea.

UI MeSH Term Description Entries
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D010405 Penicillinase A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-. beta-Lactamase I,AER-I beta-Lactamase,Benzylpenicillinase,Carbenicillinase,Exopenicillinase,beta Lactamase III,beta Lactamase RP4,gamma-Penicillinase,AER I beta Lactamase,Lactamase RP4, beta,beta Lactamase I,beta-Lactamase, AER-I,gamma Penicillinase
D011804 Quinolines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D015366 Pefloxacin A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. 2589 R.B.,Abactal,Peflacine,Pefloxacin Mesylate,Pefloxacin Mesylate Dihydrate,Pefloxacine,Silver Pefloxacin,Dihydrate, Pefloxacin Mesylate,Mesylate Dihydrate, Pefloxacin,Mesylate, Pefloxacin,Pefloxacin, Silver,R.B., 2589
D042462 4-Quinolones QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position. 4-Oxoquinoline,4-Quinolinone,4-Quinolone,4-Oxoquinolines,4-Quinolinones,4 Oxoquinoline,4 Oxoquinolines,4 Quinolinone,4 Quinolinones,4 Quinolone,4 Quinolones

Related Publications

K P Chan, and E H Sng, and S T Koh
December 2016, MLO: medical laboratory observer,
K P Chan, and E H Sng, and S T Koh
April 1996, Infection and immunity,
K P Chan, and E H Sng, and S T Koh
April 1967, The Medical journal of Australia,
K P Chan, and E H Sng, and S T Koh
January 1990, Lancet (London, England),
K P Chan, and E H Sng, and S T Koh
January 1968, Antimicrobial agents and chemotherapy,
K P Chan, and E H Sng, and S T Koh
June 1981, The British journal of venereal diseases,
K P Chan, and E H Sng, and S T Koh
July 1978, The Journal of antimicrobial chemotherapy,
K P Chan, and E H Sng, and S T Koh
January 1979, The Journal of antimicrobial chemotherapy,
K P Chan, and E H Sng, and S T Koh
November 1982, Antimicrobial agents and chemotherapy,
K P Chan, and E H Sng, and S T Koh
November 1972, Canadian Medical Association journal,
Copied contents to your clipboard!